MAIA
MAIA
AMEX · Biotechnology

Maia Biotechnology Inc

$1.32
+0.01 (+0.76%)
As of May 16, 2:16 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,565.9% upside
Low Target $18.66
Average Target $21.99
High Target $31.61
Current Price $1.32
Current
$1.32
Target
$21.99
$18.66 $21.99 avg $31.61
Scenario Analysis
Bear Case
$18.66
1,313.6%
Low target
Base Case
$21.99
+1,565.9%
Avg target
Bull Case
$31.61
+2,294.7%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$3.19
-58.6% from high
52-Week Low
$0.87
+51.7% from low
Target vs 52W High
$21.99
+589.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%